Blood Pressure Lowering in Type 2 Diabetes
University of Oxford · George Institute for Global Health · +2 more institutions
Abstract
Lowering blood pressure (BP) is widely used to reduce vascular risk in individuals with diabetes.
To determine the associations between BP-lowering treatment and vascular disease in type 2 diabetes. DATA SOURCES AND STUDY SELECTION: We searched MEDLINE for large-scale randomized controlled trials of BP-lowering treatment including patients with diabetes, published between January 1966 and October 2014. DATA EXTRACTION AND SYNTHESIS: Two reviewers independently extracted study characteristics and vascular outcome data. Estimates were stratified by baseline BP and achieved BP, and pooled using fixed-effects meta-analysis. MAIN OUTCOMES AND MEASURES: All-cause mortality, cardiovascular events, coronary heart disease events, stroke, heart failure, retinopathy, new or worsening albuminuria, and renal failure.
Citation impact
- FWCI
- 67.27
- Percentile
- 100%
- References
- 81
Authors
6- CAConnor A. EmdinCorresponding
University of Oxford, George Institute for Global Health
- KRKazem Rahimi
University of Oxford, George Institute for Global Health
- BNBruce Neal
University of Sydney, The George Institute for Global Health
- TCThomas Callender
University of Oxford, George Institute for Global Health
- VPVlado Perkovic
University of Sydney, The George Institute for Global Health
Topics & keywords
- Medicine
- Internal medicine
- Relative risk
- Albuminuria
- Type 2 diabetes
- Heart failure
- Stroke (engine)
- Blood pressure
- Good health and well-being